RT Journal Article
SR Electronic
T1 Children develop strong and sustained cross-reactive immune responses against spike protein following SARS-CoV-2 infection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.12.21255275
DO 10.1101/2021.04.12.21255275
A1 Dowell, Alexander C.
A1 Butler, Megan S.
A1 Jinks, Elizabeth
A1 Tut, Gokhan
A1 Lancaster, Tara
A1 Sylla, Panagiota
A1 Begum, Jusnara
A1 Pearce, Hayden
A1 Taylor, Graham S.
A1 Syrimi, Eleni
A1 Spalkova, Eliska
A1 Davies, Sandra
A1 Baawuah, Frances
A1 Beckmann, Joanne
A1 Okike, Ifeanyichukwu
A1 Ahmad, Shazaad
A1 Garstang, Joanna
A1 Brent, Andrew J
A1 Brent, Bernadette
A1 Ireland, Georgina
A1 Aiano, Felicity
A1 Amin-Chowdhury, Zahin
A1 Jones, Samuel
A1 Borrow, Ray
A1 Linley, Ezra
A1 Poh, John
A1 Saliba, Vanessa
A1 Amirthalingam, Gayatri
A1 Brown, Kevin E
A1 Ramsay, Mary E
A1 Zuo, Jianmin
A1 Moss, Paul
A1 Ladhani, Shamez
YR 2021
UL http://medrxiv.org/content/early/2021/04/19/2021.04.12.21255275.abstract
AB SARS-CoV-2 infection is generally mild or asymptomatic in children but the biological basis for this is unclear. We studied the profile of antibody and cellular immunity in children aged 3-11 years in comparison with adults. Antibody profiles in children were strong with high titres against spike protein and receptor binding domain (RBD). SARS-CoV-2 seroconversion in children strongly boosted antibody responses against seasonal beta-coronaviruses, partly through cross-recognition of the S2 domain, indicating a broad humoral response that was not seen in adults. T cell responses against spike were also >2-fold higher in children compared to adults and displayed a strong Th1 cytokine profile. SARS-CoV-2 spike-reactive cellular responses were present in more than half the seronegative children, indicating pre-existing cross-reactive responses or sensitization against SARS-CoV-2. Importantly, all children retained high antibody titres and cellular responses for more than 6 months after infection whilst relative antibody waning was seen in adults. Children thus distinctly generate robust, cross-reactive and sustained immune responses after SARS-CoV-2 infection with focussed specificity against spike protein. These observations demonstrate several novel features of SARS-CoV-2-specific immune responses in children and may provide insights into relative clinical protection in this group. Such information on the profile of natural infection will help to guide the introduction of vaccination regimens into the paediatric population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was part funded by the MRC and the UK Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:PHE Research Ethics Governance Group (reference NR0209; May 16, 2020)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available following reasonable requests.